The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) is establishing eleven new Collaborative Research Centers (CRC) to promote world-class research at universities. This was announced by the relevant Grants Committee, which met by video conference due to the coronavirus pandemic.
E-Mail
The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) is establishing eleven new Collaborative Research Centres (CRC) to promote world-class research at universities. This was announced by the relevant Grants Committee, which met by video conference due to the coronavirus pandemic. The new CRCs will initially receive a total of approximately €138 million over a period of four years from 1 July 2021 onwards. This includes a 22-percent programme allowance for indirect project-related costs. Seven of the new consortia are CRC/Transregios (TRR) distributed across multiple applicant universities.
As well as the eleven new groups, the Grants Committee agreed to extend the funding of another 27 CRCs for an additional funding period, including four CRC/Transregios. Collaborative Research Centres allow researchers to tackle innovative, challenging and long-term research projects within the network and should enable institutional priority area development and struc
SARS-CoV-2 RNA analysis reveals potential treatment targets drugtargetreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from drugtargetreview.com Daily Mail and Mail on Sunday newspapers.
Cells are the building blocks of life, present in every living organism. But how similar do you think your cells are to a mouse? A fish? A worm? Comparing
New study may pave way for novel therapeutic strategies for COVID-19
An international and multidisciplinary team led by researchers at the University of Oxford, University of Glasgow, and University of Heidelberg, has uncovered the interactions that SARS-CoV-2 RNA establishes with the host cell, many of which are fundamental for infection. These discoveries pave the way for the development of new therapeutic strategies for COVID-19 with broad-range antiviral potential.
The genetic information of SARS-CoV-2 is encoded in an RNA molecule instead DNA. This RNA must be multiplied, translated, and packaged into new viral particles to produce the viral progeny. Despite the complexity of these processes, SARS-CoV-2 only encodes a handful of proteins able to engage with viral RNA. To circumvent this